Manipal Hospitals
Neuroblastoma treatment cost in India typically runs from AUD $17 to AUD $58 for initial specialist reviews, with complex treatment of neuroblastoma ranging from AUD $35,226 to AUD $74,765. Total expenses depend on the cancer risk level and the need for advanced therapies. Patients save approximately 70% to 80% compared to Australia and the US. Top treatment hubs include Mumbai, Bengaluru, and Delhi.
Typical Neuroblastoma Treatment Costs in India
Bookimed Expert Insight: Advanced neuroblastoma cases benefit from multidisciplinary centres like Global Hospital Chennai, which specializes in complex bone marrow transplants. For patients needing the latest protocols, Fortis Gurgaon is ranked as one of the most technically advanced hospitals globally. Families seeking integrated care should consider HCG Manavata Cancer Centre, where over 40 consultant oncologists use immunotherapy to treat pediatric solid tumours.
| India | Thailand | Turkey | |
| Complex treatment of neuroblastoma | from AUD $35,226 | from AUD $64,701 | from AUD $40,258 |
No hidden fees – just official clinic prices. Pay at the clinic for Neuroblastoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Neuroblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Neuroblastoma treatment journey.
Dr Shruti Kate is a highly trained medical oncologist with specialist expertise from the Tata Memorial Hospital, world-renowned for treating complex paediatric tumours.
Professor Gaurav Kharya is a specialist in paediatric haematology and oncology who leads the bone marrow transplant unit at Artemis Hospitals.
Survival rates for neuroblastoma in India vary significantly between 8.7% and 80%. The rate depends largely on the disease stage at diagnosis. Localised cases show high survival. However, advanced stage IV cases often report a 2-year survival rate of approximately 30%. This low rate is due to late detection.
Bookimed Expert Insight: Clinical volume is a major indicator of quality in Indian oncology. HCG Manavata Cancer Centre has treated 25,000+ radiotherapy patients and maintains a US-FDA-audited research institute. Choosing centres with high paediatric caseloads and JCI accreditation, such as BLK Super Speciality Hospital. This provides access to international safety standards. These high-volume hubs are better equipped to manage the intensive treatment protocols required for stage III and IV neuroblastoma.
India provides several treatments for relapsed neuroblastoma. Specialists offer CAR NK cell therapy and MIBG targeted radiotherapy. Immunotherapy and metronomic therapy are available at major oncology hubs. These centres follow international protocols for complex paediatric cases and stem cell rescue.
Bookimed Expert Insight: Indian oncology centres often provide treatments like metronomic therapy and immunotherapy at 30% to 50% lower costs than European clinics. This makes continuous, long-term protocols more accessible for international families. Centres such as HCG Manavata have performed over 65,000 cancer surgeries, demonstrating extensive clinical experience with complex tumours.
Patient Consensus: Patients note that primary oncologists are the best resource for finding trials. Families should specifically ask about clinical protocols for high-risk relapses in India.
Children in India undergo a structured follow-up program featuring clinical exams, blood tests, and imaging to detect recurrence. Monitoring typically follows the International Neuroblastoma Staging System. Specialists use contrast-enhanced CT or MRI scans and MIBG scans. These scans track high-risk cases after treatment ends.
Bookimed Expert Insight: Indian cancer centres like HCG Manavata Cancer Centre often maintain US-FDA audited research units. This is notable as doctors such as Dr Shruti Kate are members of international bodies like ASCO. This global alignment means children receive monitoring protocols matching Australian or European standards. These protocols are for high-risk neuroblastoma.
Patient Consensus: Parents note that follow-up scans often continue for 3 years post-treatment. They highlight the need for families to be proactive advocates. Families should have every scan result scrutinised in India.